Molecular cytogenetic analysis of genomic instability at the 1q12-22 chromosomal site in B-cell non-Hodgkin lymphoma

Genes Chromosomes and Cancer

Volumn 35, Issue 4, 2002, Pages 318-328

  Itoyama, Takahiro ^a   Nanjungud, Gouri ^a   Chen, Weiyi ^a   Dyomin, Vadim G ^a   Teruya Feldstein, Julie ^a   Jhanwar, Suresh C ^a   Zelenetz, Andrew D ^a   Chaganti, R S K ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN IG; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; CHROMOSOMAL LOCALIZATION; CHROMOSOME 1Q; CHROMOSOME ANALYSIS; CHROMOSOME INVERSION; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYTOGENETICS; DNA STRAND BREAKAGE; GENE CONTROL; GENE DUPLICATION; GENE LOCUS; GENE MAPPING; GENE TRANSLOCATION; GENETIC STABILITY; HETEROCHROMATIN; HISTOPATHOLOGY; HUMAN; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

CHROMOSOME ABERRATIONS; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOME PAINTING; CHROMOSOMES, HUMAN, PAIR 1; COHORT STUDIES; CYTOGENETIC ANALYSIS; FEMALE; GENETIC MARKERS; HETEROCHROMATIN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INVERSION, CHROMOSOME; LYMPHOMA, B-CELL; MALE; NEOPLASM PROTEINS; PROSPECTIVE STUDIES; TRANSLOCATION, GENETIC;

EID: 0036883556     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10120     Document Type: Article

References (31)

1. Bailey JA, Yavor AM, Massa HF, Trask BJ, Eichler EE. 2001. Segmental duplications: Organization and impact within the current human genome project assembly. Genome Res 11:1005-1017.
2. Bajalica S, Sorensen AG, Pedersen NT, Heim S, Brondum-Nielsen K. 1993. Chromosome painting as a supplement to cytogenetic banding analysis in non-Hodgkin lymphoma. Genes Chromosomes Cancer 7:231-239.
3. Berger R, Busson-Le Coniat M. 1999. Centric and pericentric chromosome rearrangements in hematopoietic malignancies. Leukemia 13:671-678.
4. Busson-Le Coniat M, Salomon-Nguyen F, Dastugue N, Maarek O, Lafage-Pochitaloff M, Mozziconacci MJ, Baranger L, Brizard F, Radford I, Jeanpierre M, Bernard OA, Berger R. 1999. Fluorescence in situ hybridization analysis of chromosome 1 abnormalities in hematopoietic disorders: Rearrangements of DNA satellite II and new recurrent translocations. Leukemia 13:1975-1981.
5. Callanan MB, Le Baccon P, Mossuz P, Duley S, Bastard C, Hamoudi R, Dyer MJ, Klobeck G, Rimokh R, Sotto JJ, Leroux D. 2000. The IgG Fc receptor, FcγRIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma. Proc Natl Acad Sci USA 97:309-314.
6. Chaganti RSK, Nanjangud G, Schmidt H, Teruya-Feldstein J. 2000. Recurring chromosomal abnormalities in non-Hodgkin's lymphoma: Biologic and clinical significance. Semin Hematol 37:396-411.
7. Chen W, Palanisamy N, Schmidt H, Teruya-Feldstein J, Jhanwar SC, Zelenetz AD, Houldsworth J, Chaganti RSK. 2001. Deregulation of FCGR2B expression by 1q21 rearrangements in follicular lymphomas. Oncogene 20:7686-7693.
8. Cheung TH, Chung TK, Poon CS, Hampton GM, Wang VW, Wong YF. 1999. Allelic loss on chromosome 1 is associated with tumor progression of cervical carcinoma. Cancer 86:1294-1298.
9. Cigudosa JC, Parsa NZ, Louie DC, Filippa DA, Jhanwar SC, Johansson B, Mitelman F, Chaganti RSK. 1999. Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas. Genes Chromosomes Cancer 25:123-133.
10. Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M. 1997. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 89:215-225.
11. Dyomin VG, Palanisamy N, Lloyd KO, Dyomina K, Jhanwar SC, Houldsworth J, Chaganti RSK. 2000. MUC1 is activated in a B-cell lymphoma by the t(1;14)(q21;q32) translocation and is rearranged and amplified in B-cell lymphoma subsets. Blood 95: 2666-2671.
12. Gilles F, Goy A, Remache Y, Shue P, Zelenetz AD. 2000. MUC1 dysregulation as the consequence of a t(1;14)(q21;q32) translocation in an extranodal lymphoma. Blood 95:2930-2936.
13. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. 1999. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory, Committee meeting, Airlie House, Virginia, November 1997. Ann Oncol 10:1419-1432.
14. Hatzivassiliou G, Miller I, Takizawa J, Palanisamy N, Rao PH, Iida S, Tagawa S, Taniwaki M, Russo J, Neri A, Cattoretti G, Clynes R, Mendelsohn C, Chaganti RS, Dalla-Favera R. 2001. IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity 14:277-289.
15. Hellman A, Zlotorynski E, Scherer SW. Cheung J, Vincent JB, Smith DI, Trakhtenbrot L, Kerem B. 2002. A role for common fragile site induction in amplification of human oncogenes. Cancer Cell 1:89-97.
16. Henikoff S. 2000. Heterochromatin function in complex genomes. Biochim Biophys Acta 1470:01-08.
17. Hernandez R, Frady A, Zhang XY, Varela M, Ehrlich M. 1997. Preferential induction of chromosome 1 multibranched figures and whole-arm deletions in a human pro-B cell line treated with 5-azacytidine or 5-azadeoxycytidine. Cytogenet Cell Genet 76: 196-201.
18. International Human Genome Sequencing Consortium. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921.
19. ISCN. 1995. An international system for human cytogenetic nomenclature. Mitelman F, editor. Basel: S. Karger.
20. Le Baccon P, Leroux D, Dascalescu C, Duley S, Marias D, Esmenjaud E, Sotto JJ, Callanan M. 2001. Novel evidence of a role or chromosome 1 pericentric heterochromatin in the pathogenesis of B-cell lymphoma and multiple myeloma. Genes Chromosomes Cancer 32:250-264.
21. Mazzarella R, Schlessinger D. 1998. Pathological consequences of sequence duplications in the human genome. Genome Res 8:1007-1021.
22. Mitelman F, Mertens F, Johansson B. 1997. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15:417-474.
23. Offit K, Wong G, Filippa DA, Tao Y, Chaganti RSK. 1991. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Clinical correlations. Blood 77:1508-1515.
24. Qu GZ, Grundy PE, Narayan A, Ehrlich M. 1999. Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16. Cancer Genet Cytogenet 109:34-39.
25. Rao PH, Cigudosa JC, Ning Y, Calasanz MJ, Iida S, Tagawa S, Michaeli J, Klein B, Dalla-Favera R, Jhanwar SC, Ried T, Chaganti RSK. 1998a. Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma. Blood 92:1743-1748.
26. Rao PH, Houldsworth J, Dyomina K, Parsa NZ, Cigudosa JC, Louie DC, Popplewell L, Offit K, Jhanwar SC, Chaganti RSK. 1998b. Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood 92:234-240.
27. Sager R. 1979. Transposable elements and chromosomal rearrangements in cancer - A possible link. Nature 282:447-449.
28. Takahashi T, Mitsuda T, Okuda K. 1989. An alternative nonradio-active method for labeling DNA using biotin. Anal Biochem 179:77-85.
29. Willis TG, Zalcberg IR, Coignet LJ, Wlodarska I, Stul M, Jadayel DM, Bastard C, Treleaven JG, Catovsky D, Silva ML, Dyer MJ. 1998. Molecular cloning of translocation t(1;14)(q21;q3.2) defines a novel gene (BCL9) at chromosome 1q.21. Blood 91:1873-1881.
30. Winfield SL, Tayebi N. Martin BM, Ginns EI, Sidransky E. 1997. Identification of three additional genes contiguous to the glucocerebrosidase locus on chromosome 1q21: Implications for Gaucher disease. Genome Res 7:1020-1026.
31. Xu GL, Bestor TH, Bourc'his D. Hsieh CL, Tommerup N, Bugge M, Hulten M, Qu X, Russo JJ, Viegas-Pequignot E. 1999. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402:187-191.